AEGERION PHARMACEUTICALS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.97 USD | +5.35% |
|
+4.23% | -80.50% |
| 2015 | AbbVie : Venture capitalists ride biotech wave one drug at a time | RE |
| 2015 | Aegerion Pharmaceuticals : Exclusive: Top investors push Aegerion to oust CEO, consider sale - sources | RE |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
More news
More press releases
More news
| 1 day | +5.35% |
| Managers | Title | Age | Since |
|---|---|---|---|
Sheila Frame
PSD | President | 62 | - |
Elizabeth Jobes
BRD | Director/Board Member | 57 | - |
Ailish Hogan
SEC | Corporate Secretary | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sheila Frame
PSD | President | 62 | - |
Elizabeth Jobes
BRD | Director/Board Member | 57 | - |
| 1st Jan change | Capi. | |
|---|---|---|
| +32.09% | 693B | |
| +29.39% | 584B | |
| -1.34% | 372B | |
| +20.34% | 332B | |
| +7.39% | 294B | |
| +14.25% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +8.49% | 168B |
- Stock Market
- Equities
- AEGR Stock